Publication | Open Access

Efficacy and safety of subcutaneous spesolimab for the prevention of generalised pustular psoriasis flares (Effisayil 2): an international, multicentre, randomised, placebo-controlled trial

Effisayil 2MedicineClinical DermatologyPlacebo-controlled TrialSubcutaneous SpesolimabDermatologyPsoriatic Arthritis